Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery.
Xiang D, Shigdar S, Bean AG, Bruce M, Yang W, Mathesh M, Wang T, Yin W, Tran PH, Al Shamaileh H, Barrero RA, Zhang PZ, Li Y, Kong L, Liu K, Zhou SF, Hou Y, He A, Duan W.
Xiang D, et al. Among authors: tran ph.
Theranostics. 2017 Sep 20;7(17):4071-4086. doi: 10.7150/thno.20168. eCollection 2017.
Theranostics. 2017.
PMID: 29158811
Free PMC article.